OUR SOLUTION
Kamari Pharma is a biopharmaceutical company that is developing novel TRPV3 inhibitors that may repair the cycle of molecular and local damage in rare dermatologic diseases involving Ca⁺⁺ regulation.
Kamari Pharma is a biopharmaceutical company that is developing novel TRPV3 inhibitors that may repair the cycle of molecular and local damage in rare dermatologic diseases involving Ca⁺⁺ regulation.